In this video

Share

Sohn Conference: Raising the red flag on drug makers

Richard Marshaal, Senvest Management founder and CEO, who oversees about $1.5 billion in assets, explains why he thinks shares of Insys Therapeutics could sell off.
01:58
Tue, Oct 3 20174:51 AM EDT